$ANIK Cashflow Statement | Understand Stock

$ANIK

$21.35 +$0.08 (0.38%) Close

$ANIK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net loss
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity
Depreciation
Amortization of acquisition related intangible assets
Amortization of acquisition related inventory step-up
Non-cash operating lease cost
Goodwill impairment charge
Change in fair value of contingent consideration
(Gain) loss on sale of assets
Loss on impairment of long-lived assets
Stock-based compensation expense
Deferred income taxes
Provision for doubtful accounts
Provision for inventory
Other
Interest income on notes receivable

Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital
Accounts receivable
Inventories
Prepaid expenses, other current and long-term assets
Accounts payable
Operating lease liabilities
Accrued expenses, other current and long-term liabilities
Income taxes
Payments of contingent consideration
Net cash provided by (used in) operating activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Acquisition of Parcus Medical and Arthrosurface, net of cash acquired
Proceeds from maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from sale of Parcus
Notes receivable
Proceeds from sale of intangible assets
Acquisition of intangible assets
Net cash used in investing activities

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Payments made on finance leases
Proceeds from long-term debt
Repayments of long-term debt
Repurchases of common stock
Proceeds from employee stock purchase program
Cash paid for tax withheld on vested restricted stock awards
Proceeds from exercises of equity awards
Payments of contingent consideration
Net cash used in financing activities

us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract
Exchange rate impact on cash
Decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Cash Flow Information
Cash paid for income taxes, net of refunds
Right-of-use assets obtained in exchange for operating lease liabilities
Accounting Standards Update 2016-02
Total right-of-use assets obtained in exchange for operating lease liabilities
Noncash Investing and Financing Items
Purchases of property and equipment included in accounts payable and accrued expenses
Consideration for acquisitions included in accounts payable and accrued expenses
Contingent consideration fair value on acquisition date
Notes receivable

Comments